BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schilling S, Fusco FM, De Iaco G, Bannister B, Maltezou HC, Carson G, Gottschalk R, Brodt HR, Brouqui P, Puro V, Ippolito G; European Network for Highly Infectious Diseases project members. Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries. PLoS One 2014;9:e100401. [PMID: 25350843 DOI: 10.1371/journal.pone.0100401] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Herstein JJ, Biddinger PD, Kraft CS, Saiman L, Gibbs SG, Smith PW, Hewlett AL, Lowe JJ. Initial Costs of Ebola Treatment Centers in the United States. Emerg Infect Dis 2016;22:350-2. [PMID: 26812203 DOI: 10.3201/eid2202.151431] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
2 Fusco FM, Brouqui P, Ippolito G; EuroNHID Working Group. Highly infectious diseases in the Mediterranean Sea area: Inventory of isolation capabilities and recommendations for appropriate isolation. New Microbes New Infect 2018;26:S65-73. [PMID: 30402245 DOI: 10.1016/j.nmni.2018.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Brosh-Nissimov T. Lassa fever: another threat from West Africa. Disaster Mil Med 2016;2:8. [PMID: 28265442 DOI: 10.1186/s40696-016-0018-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
4 Gagnaire J, Gagneux-Brunon A, Pouvaret A, Grattard F, Carricajo A, Favier H, Mattei A, Pozzetto B, Nuti C, Lucht F, Berthelot P, Botelho-Nevers E. Carbapenemase-producing Acinetobacter baumannii: An outbreak report with special highlights on economic burden. Med Mal Infect 2017;47:279-85. [PMID: 28343727 DOI: 10.1016/j.medmal.2017.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Schilling S, Brodt HR. [Specialized clinical facilities for the treatment of highly contagious, life-threatening infectious diseases : a comparison between Germany and 15 European nations]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015;58:671-8. [PMID: 26104541 DOI: 10.1007/s00103-015-2161-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 de Jong MD, Reusken C, Horby P, Koopmans M, Bonten M, Chiche J, Giaquinto C, Welte T, Leus F, Schotsman J, Goossens H; PREPARE consortium and affiliated clinical networks. Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014. Euro Surveill 2014;19:20980. [PMID: 25496571 DOI: 10.2807/1560-7917.es2014.19.48.20980] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
7 Nicastri E, Castilletti C, Biava M, Fusco FM, Petrosillo N, Puro V, Lauria FN, Capobianchi MR, Di Caro A, Ippolito G. Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani. Adv Exp Med Biol 2017;972:103-22. [PMID: 27864803 DOI: 10.1007/5584_2016_134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Leone M, Bernard L, Brouqui P. Ebola virus outbreak: Tribute to the French Army Health Services. Anaesthesia Critical Care & Pain Medicine 2015;34:307-8. [DOI: 10.1016/j.accpm.2015.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Kang JS, Jhun BW, Yoon H, Lim SM, Ko E, Park JH, Hwang SY, Lee SU, Lee TR, Cha WC, Shin TG, Sim MS, Jo IJ. The Utility of Preliminary Patient Evaluation in a Febrile Respiratory Infectious Disease Unit outside the Emergency Department. J Korean Med Sci 2017;32:1534-41. [PMID: 28776351 DOI: 10.3346/jkms.2017.32.9.1534] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Ippolito G, Puro V, Brouqui P, Lauria FN, Fusco FM, on behalf of the Euronhid Consortium C. Letter to the editor: Management of patients with Ebola virus disease in Europe: high-level isolation units should have a key role. Eurosurveillance 2014;19. [DOI: 10.2807/1560-7917.es2014.19.50.20993] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
11 Therkorn J, Drewry Iii D, Pilholski T, Shaw-Saliba K, Bova G, Maragakis LL, Garibaldi B, Sauer L. Impact of air-handling system exhaust failure on dissemination pattern of simulant pathogen particles in a clinical biocontainment unit. Indoor Air 2019;29:143-55. [PMID: 30192402 DOI: 10.1111/ina.12506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Le AB, Biddinger PD, Smith PW, Herstein JJ, Levy DA, Gibbs SG, Lowe JJ. A Highly Infectious Disease Care Network in the US Healthcare System. Health Secur 2017;15:282-7. [PMID: 28636444 DOI: 10.1089/hs.2016.0073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
13 Toyokawa T, Hori N, Kato Y. Preparedness at Japan's Hospitals Designated for Patients with Highly Infectious Diseases. Health Secur 2017;15:97-103. [PMID: 28192052 DOI: 10.1089/hs.2016.0056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Herstein JJ, Biddinger PD, Gibbs SG, Le AB, Jelden KC, Hewlett AL, Lowe JJ. Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers. Emerg Infect Dis 2017;23:965-7. [PMID: 28518036 DOI: 10.3201/eid2306.170062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
15 Brosh-nissimov T, Poles L, Kassirer M, Singer R, Kaliner E, Shriki DD, Anis E, Fogel I, Engelhard D, Grotto I; on behalf of the Israeli Epidemic Management Team. Preparing for imported Ebola cases in Israel, 2014 to 2015. Eurosurveillance 2015;20. [DOI: 10.2807/1560-7917.es.2015.20.44.30054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
16 Tartari E, Allegranzi B, Ang B, Calleja N, Collignon P, Hopman J, Lang L, Lee LC, Ling ML, Mehtar S, Tambyah PA, Widmer A, Voss A. Preparedness of institutions around the world for managing patients with Ebola virus disease: an infection control readiness checklist. Antimicrob Resist Infect Control 2015;4:22. [PMID: 26056563 DOI: 10.1186/s13756-015-0061-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]